Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Terminated Phase 3 Interventional

A Study of Aticaprant 10 mg as Adjunctive Therapy in Adult Participants With Major Depressive Disorder (MDD) With Moderate-to-severe Anhedonia and Inadequate Response to Current Antidepressant Therapy and Long-term Extension Treatment With Aticaprant

ClinicalTrials.gov ID: NCT06514742

Public ClinicalTrials.gov record NCT06514742. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced May 19, 2026, 10:07 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Randomized, Double-blind, Multicenter, Placebo-controlled Study to Evaluate the Efficacy, Safety, and Tolerability of Aticaprant 10 mg as Adjunctive Therapy in Adult Participants With Major Depressive Disorder (MDD) With Moderate-to-severe Anhedonia and Inadequate Response to Current Antidepressant Therapy and an Open Label Long-term Extension Treatment With Aticaprant

Study identification

NCT ID
NCT06514742
Recruitment status
Terminated
Study type
Interventional
Phase
Phase 3
Lead sponsor
Janssen Research & Development, LLC
Industry
Enrollment
101 participants

Conditions and interventions

Interventions

  • Aticaprant Drug
  • Placebo Other

Drug · Other

Eligibility (public fields only)

Age range
18 Years to 64 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Jun 25, 2024
Primary completion
Apr 7, 2025
Completion
Apr 23, 2025
Last update posted
Feb 16, 2026

2024 – 2025

United States locations

U.S. sites
39
U.S. states
16
U.S. cities
36
Facility City State ZIP Site status
UAB Huntsville Regional Medical Campus Huntsville Alabama 35801
IMA Clinical Research PC Phoenix Arizona 85012
Noble Clinical Research Tucson Arizona 85704
Advanced Research Center Inc Anaheim California 92805
CI Trials Bellflower California 90706
Behavioral Research Specialists LLC Glendale California 91206
Sun Valley Research Center Imperial California 92251
ATP Clinical Research Orange California 92866
Lumos Clinical Research Center LLC San Jose California 95124
Viking Clinical Research Ltd Temecula California 92591
Sunwise Clinical Research Walnut Creek California 94596
MCB Clinical Research Centers LLC Colorado Springs Colorado 80910
Humanity Clinical Research Corp Aventura Florida 33180
Elligo Independent Research Sites Mindful Behavioral Health Boca Raton Florida 33431
Gulfcoast Medical Research Center Fort Myers Florida 33912
New Life Medical Research Center, Inc. Hialeah Florida 33012
LCC Medical Research Institute Inc Miami Florida 33126
Floridian Clinical Research LLC Miami Florida 33135
Medquest Translational Sciences Miami Lakes Florida 33016
Best Choice Medical and Research Service Pembroke Pines Florida 33024
K2 Medical Research Tampa Florida 33607
Neuroscience Research Institute West Palm Beach Florida 33407
Accelerated Clinical Trials LLC Peachtree Corners Georgia 30071
Southern Illinois University School of Medicine Springfield Illinois 62702
DelRicht Research New Orleans Louisiana 70115
CBH Health Gaithersburg Maryland 20877
Integrative Clinical Trials LLC Brooklyn New York 11229
Fieve Clinical Research Inc New York New York 10017
New Hope Clinical Research Charlotte North Carolina 28211
Patient Priority Clinical Sites LLC Cincinnati Ohio 45215
OSU Department of Psychiatry and Behavioral Health Columbus Ohio 43210
Conrad Clinical Research Edmond Oklahoma 73013
Suburban Research Associates Media Pennsylvania 19063
UTHealth Houston Center for Interventional Psychiatry Houston Texas 77030
Brain Health Consultants Houston Texas 77046
Red Oak Psychiatry Associates Houston Texas 77090
Revival Research Institute LLC McKinney Texas 75071
Perceptive Pharma Research Richmond Texas 77407
Northwest Clinical Research Center Bellevue Washington 98007

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 45 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT06514742, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Feb 16, 2026 · Synced May 19, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT06514742 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →